Cardinal Health (NYSE:CAH) Releases FY25 Earnings Guidance

Cardinal Health (NYSE:CAH) issued an update on its FY25 earnings guidance on Thursday morning. The company provided earnings per share guidance of at least $7.50 for the period, compared to the consensus earnings per share estimate of $7.89. Cardinal Health also updated its FY24 guidance to $7.30-7.40 EPS.

Cardinal Health Stock Down 4.0 %

CAH traded down $4.07 during trading on Friday, reaching $98.91. The company had a trading volume of 3,446,183 shares, compared to its average volume of 2,028,678. The stock has a market cap of $24.06 billion, a P/E ratio of 43.96, a PEG ratio of 0.99 and a beta of 0.71. The business has a 50 day simple moving average of $109.10 and a 200-day simple moving average of $105.09. Cardinal Health has a 52 week low of $77.56 and a 52 week high of $116.04.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, May 2nd. The company reported $2.08 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.13. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The business had revenue of $54.90 billion for the quarter, compared to analyst estimates of $56.05 billion. During the same quarter last year, the firm posted $1.74 earnings per share. The business’s revenue was up 8.7% compared to the same quarter last year. As a group, equities research analysts expect that Cardinal Health will post 7.34 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a $0.5006 dividend. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 annualized dividend and a yield of 2.02%. Cardinal Health’s dividend payout ratio (DPR) is presently 88.89%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CAH. Robert W. Baird cut their target price on Cardinal Health from $134.00 to $128.00 and set an outperform rating on the stock in a research note on Friday. UBS Group raised their price target on Cardinal Health from $122.00 to $125.00 and gave the stock a buy rating in a report on Monday, February 5th. Evercore ISI lifted their price target on Cardinal Health from $110.00 to $115.00 and gave the company an in-line rating in a research report on Friday. Leerink Partnrs reiterated an outperform rating on shares of Cardinal Health in a research report on Monday, February 26th. Finally, SVB Leerink started coverage on Cardinal Health in a research report on Monday, February 26th. They issued an outperform rating and a $125.00 price objective for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Cardinal Health currently has a consensus rating of Moderate Buy and a consensus price target of $105.79.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.